Literature DB >> 18156608

Minor emtricitabine intolerance in treatment-stable patients switched from tenofovir/lamivudine to a fixed-dose combination of tenofovir/emtricitabine (Truvada).

Rosario Palacios, Alberto Terrón, Ana Hidalgo, Antonio Rivero, Jesús Santos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18156608     DOI: 10.1093/jac/dkm489

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

Review 1.  Neuropsychiatric Effects of HIV Antiviral Medications.

Authors:  Glenn J Treisman; Olivia Soudry
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

Review 2.  Neurological and psychiatric adverse effects of antiretroviral drugs.

Authors:  Michael S Abers; Wayne X Shandera; Joseph S Kass
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

3.  Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada) in virologically suppressed HIV-infected patients on HAART.

Authors:  R Palacios; C Hidalgo; M J Ríos; A Rivero; L Muñoz; F Lozano; V Gutiérrez-Ravé; M C Gálvez; A del Arco; J Santos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-08       Impact factor: 3.267

Review 4.  Repositioned Drugs for COVID-19-the Impact on Multiple Organs.

Authors:  Sean T Foster; Kayla G Chan; Matthew J Cacace; Shay L Ladd; Christina Chan; Caleb T Sandum; Paul T Wright; Brett Volmert; Weiyang Yang; Aitor Aguirre; Wen Li; Neil T Wright
Journal:  SN Compr Clin Med       Date:  2021-04-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.